Genomics Gear Firm Pays $9.8M to Settle False Cyber Claims

US Alleged Illumina 'Knowingly' Sold Feds Systems Containing Vulnerabilities Marianne Kolbasuk McGee (HealthInfoSec) • August 1, 2025

Genomics sequencing firm Illumina Inc. has agreed to pay $9.8 million to resolve False Claims Act whistleblower allegations that it sold software and systems containing cybersecurity vulnerabilities to government agencies over more than seven years.

See Also: Post-Quantum Cryptography - A Fundamental Pillar in the Future of Cybersecurity [ES]

The U.S. Department of Justice said Illumina, which is headquartered in California but incorporated in Delaware, sold genomic sequencing systems with software containing vulnerabilities between February 2016 and September 2023 and "without having an adequate security program and sufficient quality systems to identify and address those vulnerabilities."

"Companies that sell products to the federal government will be held accountable for failing to adhere to cybersecurity standards and protecting against cybersecurity risks," said Brett Shumate, assistant attorney general of the justice department's ...